On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...